Summary:
«Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of the beta version of its new platform for next generation cytogenomic applications in the reproductive genetics and oncology spaces.»
Article written by Business Wire.
18|10|2021
Source:
Business Wire
https://www.businesswire.com/news/home/20211018005750/en/